Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew B. Klein currently holds 394,070 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew B. Klein has been a net seller of PTCT stock. They have purchased $0 and sold $4.1M worth of shares.
Matthew B. Klein's most recent insider trade was on Apr 21, 2026, when they sold 2,850 shares at $70.91 per share.
Matthew B. Klein serves as Executive at PTC THERAPEUTICS, INC. (PTCT). They have executed 45 insider transactions totaling $4.1M over their tenure at the company.
Matthew B. Klein holds the position of Executive at PTC THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Matthew B. Klein has shown a selling trading pattern, with $0 in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew B. Klein was on Aug 5, 2025, when they sold $555.6K worth of PTCT shares. This transaction involved 10,739 shares at $51.74 per share.
Matthew B. Klein currently owns 394,070 shares of PTC THERAPEUTICS, INC. (PTCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew B. Klein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew B. Klein has 45 Form 4 filings on record as an insider at PTC THERAPEUTICS, INC..
Set alerts for Matthew B. Klein and 40,000+ other insiders.